2022
DOI: 10.1007/s00125-022-05717-2
|View full text |Cite
|
Sign up to set email alerts
|

Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 39 publications
0
2
0
1
Order By: Relevance
“…A single-center retrospective study reported the use of real-time CGM over a 4-year period in neonates with hypoglycemia [ 43 ]. Although CGM has been shown to reduce morbidity in type 1 diabetes pregnancy LGA offsprings, a recent large multicenter observational cohort study on CGM with 300 pregnant women with type 1 diabetes found that neonates were more likely to be hypoglycemic [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…A single-center retrospective study reported the use of real-time CGM over a 4-year period in neonates with hypoglycemia [ 43 ]. Although CGM has been shown to reduce morbidity in type 1 diabetes pregnancy LGA offsprings, a recent large multicenter observational cohort study on CGM with 300 pregnant women with type 1 diabetes found that neonates were more likely to be hypoglycemic [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally improved fetal outcomes have not been demonstrated when compared to SMBG ( 69 ). In larger observational studies of over 300 women with type 1 diabetes, isCGM resulted in better glycaemic control in trimester 2 compared to conventional SMBG - however this translated to higher rates of neonatal hypoglycaemia and no improvement in rates of LGA or prematurity ( 72 ). The authors have suggested that the tendency of isCGM to under-read glucose readings could make patients more likely to overtreat hypoglycaemia, and thus expose themselves to rebound hyperglycaemia.…”
Section: Technologiesmentioning
confidence: 99%
“…Für isCGM bzw. FGM existieren bislang lediglich Observationsstudien mit unterschiedlichem Ergebnis [33,34], keine RCT, sodass dies zum aktuellen Zeitpunkt nicht empfohlen werden kann.…”
Section: Merkeunclassified